Hall, MD, professor and chair of radiation oncology at the Medical College of Wisconsin and medical director of Froedtert ...
Poster presentations at IMS 2026 highlighted the use of venetoclax, daratumumab, and different combination regimens across ...
Patient enrollment of the phase 3 IDeate-Lung02 trial assessing I-DXd vs chemotherapy in relapsed ES-SCLC will continue ...
At 8 years, SBRT and radical prostatectomy had similar disease control in the PACE-A trial, with less urinary incontinence ...
Resection combined with cesium-131 collagen tile-based radiation therapy (TBRT; GammaTile) significantly improved time to ...
Intensity-modulated proton therapy (IMPT) allows radiation oncologists to limit the dose to organs surrounding the prostate. That property may be particularly relevant for patients with prostate ...
Hall, MD, discussed how preoperative SBRT may serve as a platform for novel systemic therapies in pancreatic adenocarcinoma. In an interview with CancerNetwork® at the 2026 American Society for ...
Most of the KRAS inhibitors that have produced clinical data in biliary tract cancer so far target KRAS G12C, a mutation found in only a minority of patients with KRAS-mutant dise ...
William A. Hall, MD, explains how fewer visits, no concurrent chemotherapy, and adaptive MRI guidance may have preserved quality of life with SBRT.
William A. Hall, MD, explains how fewer visits, no concurrent chemotherapy, and adaptive MRI guidance may have preserved quality of life with SBRT. William A. Hall, MD, discussed how preoperative SBRT ...
Elizabeth Thompson, MD, discusses pediatric cancer, proton therapy, and her work as a peer reviewer for CURiE. In an ...
Ethan B. Ludmir, MD, explains why advanced radiation techniques like protons fit nonoperative cholangiocarcinoma better than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results